The best health and wellness news from Iceland
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
May. 4, 2026
Toxic compassion: a warning from healthcare
an hour ago
Pesticide residues in food: latest data released
Press releases
Publish your press release
2 hours ago
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
GlobeNewswire, Inc.
Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention in diabetic macular edema (DME) management Oculis is on track to report topline results in June 2026 from DIAMOND Phase 3...
Apr. 16, 2026
OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research
GlobeNewswire, Inc.
Smyrna, TN, April 16, 2026 (GLOBE NEWSWIRE) -- This report is to explain the formulation, ingredient composition, and research context behind OsteoShield with company information by Peak Health Research . It is intended for informational purposes...
Apr. 16, 2026
Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research
GlobeNewswire, Inc.
STUDIO CITY, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announces its 3rd annual Iceland Cycling Expedition, taking place August 18-24, 2026, where multiple myeloma patients, care partners, and...
Apr. 14, 2026
Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
GlobeNewswire, Inc.
SAN DIEGO, April 14, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present at the Internation...
Mar. 31, 2026
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
GlobeNewswire, Inc.
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative long-term visual outcomes, significantly...
Apr. 30, 2026
Alvotech Announces a Change in its Executive Team
GlobeNewswire, Inc.
REYKJAVIK, Iceland, April 30, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Tanya...
Video Stories
Sign up for Iceland Health Focus.
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
